InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that Moshe Mizrahy , Chairman and Chief Executive Officer, Dr. Michael Kreindel , co-founder and Chief Technology Officer, Yair Malca , Chief Financial Officer, Dr. Spero Theodorou , Chief Medical Officer, and Shakil Lakhan
|
YOKNEAM, Israel, Aug. 3, 2020 /PRNewswire/ --InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that Moshe Mizrahy, Chairman and Chief Executive Officer, Dr. Michael Kreindel, co-founder and Chief Technology Officer, Yair Malca, Chief Financial Officer, Dr. Spero Theodorou, Chief Medical Officer, and Shakil Lakhani, President of North America will participate at the following virtual conferences:  UBS Genomics 2.0 and Medtech Innovations Virtual Summit Canaccord Genuity 40th Annual Growth Conference 5th Annual Needham Virtual Med Tech 1x1 Conference To schedule a meeting please contact your salesperson or Miri Segal at msegal@ms-ir.com. A live webcast of the presentations will be available to the public at: https://inmodemd.com/investors/. The webcast will be archived for 90 days following the live presentations. About InMode InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio-frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com. Investor Relations Contact:
SOURCE InMode Ltd. |
||
Company Codes: NASDAQ-NMS:INMD |
View original content:
